These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35547465)

  • 1. Adherence to Prescribing Guideline-Directed Medical Therapy at Hospital Discharge in Subjects With Acute Coronary Syndrome, and the Relationship With Mortality.
    Alkofide H; Alshuhayb R; Alhazmi N; Almofada R; Bin Hazzaa A; Alsharif A; Abouzaid H
    Cureus; 2022 Apr; 14(4):e24000. PubMed ID: 35547465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Guideline-Directed Medical Therapy in Patients With ST-Elevation Myocardial Infarction.
    Latifi AN; Akram A; Dengle S; Minhas A; Borz-Baba C
    Cureus; 2020 Jul; 12(7):e9398. PubMed ID: 32864229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Guideline-Directed Medical Therapy and in-Hospital Major Bleeding Risk in ST-Elevation Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention: Findings from the CCC-ACS Project.
    Li Z; Yang P; A G; Sun H; Liu H; Song X; Jin Z; Li L; Hao Y; Li Y; Liu J; Zhao D; Zhou X; Yang Q;
    Cardiovasc Drugs Ther; 2023 Feb; 37(1):117-127. PubMed ID: 34599699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Oman: utilization, reasons behind non-prescribing, and dose optimization.
    Al-Aghbari S; Al-Maqbali JS; Alawi AMA; Za'abi MA; Al-Zakwani I
    Pharm Pract (Granada); 2022; 20(2):2642. PubMed ID: 35919792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study.
    Bruggmann C; Iglesias JF; Gex-Fabry M; Fesselet R; Vogt P; Sadeghipour F; Voirol P
    Am J Cardiovasc Drugs; 2020 Feb; 20(1):105-115. PubMed ID: 31300969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry.
    Chen KC; Yin WH; Wu CC; Chan SH; Wu YW; Yang Wang K; Chang KC; Hwang JJ; Voon WC; Hsieh IC; Chong JT; Lin WS; Hsu CN; Ueng KC; Hsia CP; Liu JC; Yeh JS; Mar GY; Shih JY; Kuo JY; Tsao HM; Tseng WK; Yang CH; Chang CC; Chiang CE; Lei MH; Lin JF; Shyu KG
    Acta Cardiol Sin; 2018 May; 34(3):211-223. PubMed ID: 29844642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Benefits of a Comprehensive Cardiac Rehabilitation Program for Patients with Acute Coronary Syndrome: A Follow-Up Study.
    Craciun LM; Buleu F; Pah AM; Badalica-Petrescu M; Bodea O; Man DE; Cosor OC; Iurciuc S; Dragan S; Rada M
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to guideline-directed medical therapy and 3-year clinical outcome following acute myocardial infarction.
    Lee SH; Hyun D; Choi J; Yoon CH; Cha KS; Oh S; Seong IW; Jeong MH; Choi JH
    Eur Heart J Open; 2023 Mar; 3(2):oead029. PubMed ID: 37090059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice.
    Kassab YW; Hassan Y; Aziz NA; Akram H; Ismail O
    J Eval Clin Pract; 2013 Aug; 19(4):658-63. PubMed ID: 22845427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Medical Therapy for Secondary Prevention of Acute Coronary Syndrome: A Retrospective Study from a Tertiary Hospital in Sudan.
    Ahmed KO; Ahmed AM; Wali MB; Ali AH; Azhari MM; Babiker A; Yousef BA; Muddather HF
    Ther Clin Risk Manag; 2022; 18():391-398. PubMed ID: 35431548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients.
    Srivastava PK; DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2021 Jan; 9(1):28-38. PubMed ID: 33309579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq.
    Nassr OA; Forsyth P; Johnson CF
    Pharm Pract (Granada); 2019; 17(1):1372. PubMed ID: 31015874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of proper prescribing of cardiac medications at hospital discharge for patients with acute coronary syndromes (ACS) in two Lebanese hospitals.
    Sheikh-Taha M; Hijazi Z
    Springerplus; 2014; 3():159. PubMed ID: 24790814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The independent reduction in mortality associated with guideline-directed medical therapy in patients with coronary artery disease and heart failure with reduced ejection fraction.
    Wolfe NK; Mitchell JD; Brown DL
    Eur Heart J Qual Care Clin Outcomes; 2021 Jul; 7(4):416-421. PubMed ID: 32324852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of clinical audit to improve adherence to guideline-recommended therapy in acute coronary syndrome.
    George NE; Shukkoor AA; Joseph N; Palanimuthu R; Kaliappan T; Gopalan R
    Egypt Heart J; 2022 Jan; 74(1):4. PubMed ID: 35020077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.